DK156001C - Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner - Google Patents

Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner

Info

Publication number
DK156001C
DK156001C DK278379A DK278379A DK156001C DK 156001 C DK156001 C DK 156001C DK 278379 A DK278379 A DK 278379A DK 278379 A DK278379 A DK 278379A DK 156001 C DK156001 C DK 156001C
Authority
DK
Denmark
Prior art keywords
benzazepines
mercaptos
tetrahydro
analogue
substituted
Prior art date
Application number
DK278379A
Other languages
Danish (da)
English (en)
Other versions
DK156001B (da
DK278379A (da
Inventor
Kenneth George Holden
Carl Kaiser
Original Assignee
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Corp filed Critical Smithkline Corp
Publication of DK278379A publication Critical patent/DK278379A/da
Publication of DK156001B publication Critical patent/DK156001B/da
Application granted granted Critical
Publication of DK156001C publication Critical patent/DK156001C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/22Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of halogens; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C41/00Preparation of ethers; Preparation of compounds having groups, groups or groups
    • C07C41/01Preparation of ethers
    • C07C41/18Preparation of ethers by reactions not forming ether-oxygen bonds
    • C07C41/26Preparation of ethers by reactions not forming ether-oxygen bonds by introduction of hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02Boron compounds
    • C07F5/022Boron compounds without C-boron linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
DK278379A 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner DK156001C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92261378A 1978-07-07 1978-07-07
US92261378 1978-07-07

Publications (3)

Publication Number Publication Date
DK278379A DK278379A (da) 1980-01-08
DK156001B DK156001B (da) 1989-06-12
DK156001C true DK156001C (da) 1989-11-06

Family

ID=25447325

Family Applications (1)

Application Number Title Priority Date Filing Date
DK278379A DK156001C (da) 1978-07-07 1979-07-02 Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner

Country Status (24)

Country Link
EP (2) EP0080012B1 (de)
JP (1) JPS5511584A (de)
AR (1) AR222828A1 (de)
AU (1) AU525789B2 (de)
CA (1) CA1115271A (de)
CS (1) CS213381B2 (de)
DD (1) DD147355A5 (de)
DE (1) DE2964530D1 (de)
DK (1) DK156001C (de)
ES (3) ES482276A1 (de)
FI (1) FI67215C (de)
GR (1) GR69675B (de)
HU (1) HU179315B (de)
IE (1) IE48654B1 (de)
IL (1) IL57532A (de)
IT (1) IT1193190B (de)
JO (1) JO1273B1 (de)
NO (1) NO152213C (de)
NZ (1) NZ190745A (de)
PH (1) PH15754A (de)
PL (1) PL216908A1 (de)
PT (1) PT69855A (de)
SU (1) SU1029827A3 (de)
ZA (1) ZA792785B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3119874A1 (de) 1981-05-19 1982-12-09 Dr. Karl Thomae Gmbh, 7950 Biberach "benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
US4469634A (en) * 1982-07-29 1984-09-04 Smithkline Beckman Corporation Allyloxy- and allylthio-2,3,4,5-tetrahydro-1H-3-benzazepines
US4652642A (en) * 1984-08-23 1987-03-24 Smithkline Beckman Corporation Azidobenzazepines
US4683229A (en) * 1986-03-17 1987-07-28 Smithkline Beckman Corporation 6-halo-9-alkenyleneoxy-3-alkyl-2,3,4,5-tetrahydro-(1H-3)-benzazepines and their use as selective alpha-adrenergic receptor antagonists
US6384079B1 (en) 1986-12-23 2002-05-07 Tristrata Technology, Incorporated Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging
US5942250A (en) * 1986-12-23 1999-08-24 Tristrata Technology, Inc. Compositions and methods for enhancing the topical effects of sunscreen agents
GB9119467D0 (en) * 1991-09-12 1991-10-23 Smithkline Beecham Corp Chemical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
WO2000021951A1 (en) * 1998-10-08 2000-04-20 Smithkline Beecham Plc Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
US6953787B2 (en) 2002-04-12 2005-10-11 Arena Pharmaceuticals, Inc. 5HT2C receptor modulators
ES2264003T3 (es) 2002-10-07 2006-12-16 Glaxo Group Limited Derivados de sulfonamida como agentges antipsicoticos.
CN1805938B (zh) 2003-06-17 2010-06-16 艾尼纳制药公司 用于治疗5ht2c受体相关疾病的苯并氮杂卓衍生物
PL2332921T3 (pl) 2003-06-17 2016-08-31 Arena Pharm Inc Chlorowodorek 8-chloro-1-metylo-2,3,4,5-tetrahydro-1H-3-benzazepiny
SI1720836T1 (sl) * 2004-02-25 2014-06-30 Eli Lilly And Company 6-substituirani 2,3,4,5-tetrahidro-1h-benzo (d)azepini kot agonisti 5-ht2c receptorja
NZ555981A (en) 2004-12-21 2011-01-28 Arena Pharm Inc Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
BRPI0515862A2 (pt) 2004-12-23 2011-10-11 Arena Pharm Inc uso de fentermina e agonista seletivo do receptor de 5ht-2c na preparação de composições, composições moduladoras do receptor de 5ht-2c e forma de dosagem unitária compreendendo as mesmas
EP2001852A2 (de) 2006-04-03 2008-12-17 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von 8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin und entsprechenden zwischenprodukten
CN101547892B (zh) 2006-12-05 2014-08-20 艾尼纳制药公司 制备(r)-8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的方法和其中间体
EP2288585A1 (de) 2008-03-04 2011-03-02 Arena Pharmaceuticals, Inc. Verfahren zur herstellung von mit dem 5-ht2c-agonisten (r)-8-chlor-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepin verwandten zwischenprodukten
US8952197B2 (en) 2009-06-18 2015-02-10 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
US9045431B2 (en) 2010-06-02 2015-06-02 Arena Pharmaceuticals, Inc. Processes for the preparation of 5-HT2C receptor agonists
AU2011296015B2 (en) 2010-09-01 2015-11-12 Arena Pharmaceuticals, Inc. Administration of lorcaserin to individuals with renal impairment
JP6272695B2 (ja) 2010-09-01 2018-01-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 体重管理のために有用な5−ht2cアゴニストの改変放出剤形
JP2013536859A (ja) 2010-09-01 2013-09-26 アリーナ ファーマシューティカルズ, インコーポレイテッド 5−ht2cアゴニストの非吸湿性塩
KR20130138770A (ko) 2010-09-01 2013-12-19 아레나 파마슈티칼스, 인크. 광학적으로 활성 산을 갖는 로르카세린의 염
JP2015534563A (ja) 2012-10-09 2015-12-03 アリーナ ファーマシューティカルズ, インコーポレイテッド 体重管理の方法
CN116655892B (zh) * 2023-05-18 2026-03-31 常州大学 一种交联聚合物有机电极材料及其制备方法与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2520264A (en) * 1947-08-26 1950-08-29 Maltbie Lab Inc Substituted 3, 1-benz-2, 3, 4, 5-tetrahydroazepines
US3483185A (en) * 1966-08-16 1969-12-09 American Home Prod N-substituted 2,3,4,5-tetrahydro-1h-3-benzazepines
CA974989A (en) * 1968-03-11 1975-09-23 Wallace And Tiernan Inc. Process for preparing 1,2,4,5-tetrahydro-3h,3-benzazepines and products obtained thereby
US3671519A (en) * 1969-07-14 1972-06-20 American Home Prod N-substituted 2,3,4,5,-tetrahydro-1h-3-benzazepines
US3716639A (en) 1970-03-11 1973-02-13 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepines
US3752892A (en) 1970-03-11 1973-08-14 Ciba Geigy Corp Anorexigenic tetrahydrobenzazepine derivative method and composition thereof
US4111957A (en) * 1977-02-02 1978-09-05 Smithkline Corporation Substituted 1-thienyl and furyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds
US4108989A (en) * 1977-04-01 1978-08-22 Smithkline Corporation 2,3,4,5-tetrahydro-1h-3-benzazepine-7,8-diones

Also Published As

Publication number Publication date
IE791276L (en) 1980-01-07
FI67215B (fi) 1984-10-31
JPS5511584A (en) 1980-01-26
CS213381B2 (en) 1982-04-09
JO1273B1 (en) 1986-11-30
PL216908A1 (de) 1980-08-11
JPH0153271B2 (de) 1989-11-13
NO792267L (no) 1980-01-08
SU1029827A3 (ru) 1983-07-15
CA1115271A (en) 1981-12-29
DD147355A5 (de) 1981-04-01
AU4861379A (en) 1980-02-07
IT7924165A0 (it) 1979-07-06
EP0080012A1 (de) 1983-06-01
NO152213C (no) 1985-08-28
NZ190745A (en) 1981-01-23
ES482276A1 (es) 1980-04-01
EP0080012B1 (de) 1986-04-09
AU525789B2 (en) 1982-12-02
DK156001B (da) 1989-06-12
IL57532A (en) 1982-08-31
HU179315B (en) 1982-09-28
FI67215C (fi) 1985-02-11
ES482282A1 (es) 1980-04-01
IT1193190B (it) 1988-06-02
NO152213B (no) 1985-05-13
GR69675B (de) 1982-07-07
IE48654B1 (en) 1985-04-03
PT69855A (en) 1979-08-01
DK278379A (da) 1980-01-08
DE2964530D1 (en) 1983-02-24
EP0007070B1 (de) 1983-01-19
IL57532A0 (en) 1979-10-31
ES482281A1 (es) 1980-04-01
AR222828A1 (es) 1981-06-30
FI792125A7 (fi) 1980-01-08
ZA792785B (en) 1980-08-27
EP0007070A1 (de) 1980-01-23
PH15754A (en) 1983-03-18

Similar Documents

Publication Publication Date Title
DK156001C (da) Analogifremgangsmaade til fremstilling af mercaptosubstituerede 2,3,4,5-tetrahydro-1h-3-benzazepiner
DK281079A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-2-nitroimidazoler
DK155048C (da) Analogifremgangsmaade til fremstilling af 1,8-naphthyridinforbindelser
DK162601C (da) Analogifremgangsmaade til fremstilling af 8-oe4-oe4-(2,1-benzisothiazol-3-yl)-1-piperazinylaabutylaa-8-azaspirooe4.5aadecan-7,9-dion
DK156779A (da) Fremgangsmaade til fremstilling af cycloalkyltriazoler
DK129879A (da) Fremgangsmaade til fremstilling af n-heterocyclyl-4-piperidinaminer
DK150068C (da) Analogifremgangsmaade til fremstilling af aminothiazoler
DK149846C (da) Analogifremgangsmaade til fremstilling af n,n'-bis-tetrahydro-isoquinolyldisulfonylimider
DK147178C (da) Fremgangsmaade til 1-hydroxylering af 5,6-trans-vitamin d-forbindelser
DK268579A (da) Fremgangsmaade til fremstilling af phenetamolaminer
DK504979A (da) Fremgangsmaade til fremstilling af 1,2,4,5-tetraalkyl-4-arylpiperidiner
DK117779A (da) Fremgangsmaade til fremstilling af 2,6-dialkoxybenzamider
DK444479A (da) Fremgangsmaade til fremstilling af 3,4-dihydro-3-oxo-2-quinoxaliner
DK260579A (da) Fremgangsmaade til fremstilling af 14,15-methylenderivater af oestranraekken
DK265779A (da) Fremgangsmaade til fremstilling af o-methallyloxyphenol
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
DK459579A (da) Fremgangsmaade til fremstilling af 1,2,3-thiadiazol-5-ylurinstoffer
DK150471C (da) Fremgangsmaade til fremstilling af trifluormethylphenoler
FI793444A7 (fi) Menetelmä uusien aryylitrifluorietanolien valmistamiseksi.
FI793221A7 (fi) Menetelmä substituoitujen pyrrolidiestereiden valmistamiseksi.
NO791458L (no) Fremgangsmaate til fremstilling av 1,2-dikloretan
DK185179A (da) Fremgangsmaade til fremstilling af 3-halogen-2-hydroxyalkyltrialkylammoniumunchlorider
DK145179A (da) Fremgangsmaade til fremstilling af 4-methyl-5-hydroxymethyl-imidazol
DK333579A (da) Analogifremgangsmaade til fremstilling af thiophencarboxamidoalkylmercaptaner
FI792449A7 (fi) Menetelmä uusien tiosubstituoitujen diatsasykloalkeenien valmistamiseksi.

Legal Events

Date Code Title Description
PBP Patent lapsed